Despite advances in the treatment of myocardial infarction (MI), the incidence of cardiogenic shock has remained at 7% to 10% during the last 25 years. Hospital mortality was about 90% in the ...

The following is a summary of “Corticosteroids in Cardiogenic Shock: A Retrospective Analysis of the Medical Information Mart ...

The following is a summary of “Patient Characteristics, Management and Long-term Outcomes of Patients with Cardiogenic Shock ...

Are you searching for effective medications to treat 'Cardiogenic Shock'? This comprehensive guide provides the latest information on medications-both generic and branded-that are essential for ...

focusing on dose optimization and the therapeutic potential of istaroxime’s novel SERCA2a mechanism. It involves patients ...

This is also the mechanism that local anesthetics work ... when there are signs of cardiogenic shock, severe bradycardia, hypotension or wheezing related to asthma. Beta-blockers are ...

Its dual mechanism aims to improve cardiac output ... 2 trials involving patients with acute heart failure and early ...

The exact pathophysiology of Takotsubo cardiomyopathy ... There are two potential causes when cardiogenic shock results from stress-induced cardiomyopathy, and it is very important to distinguish ...